Literature DB >> 21171824

Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation.

Raine Tatara1, Katsutoshi Ozaki, Yuji Kikuchi, Keiko Hatanaka, Iekuni Oh, Akiko Meguro, Haruko Matsu, Kazuya Sato, Keiya Ozawa.   

Abstract

BACKGROUND AIMS: A previous study has demonstrated that mouse mesenchymal stromal cells (MSC) produce nitric oxide (NO), which suppresses signal transducer and activator of transcription (STAT) 5 phosphorylation and T-cell proliferation under neutral and T helper 1 cells (Th1) conditions. We aimed to determine the effects of MSC on T helper 17 cells (Th17) and regulatory T-cell (T-reg) differentiation.
METHODS: CD4 T cells obtained from mouse spleen were cultured in conditions for Th17 or Treg differentiation with or without mouse MSC. Th17 and Treg differentiation was assessed by flow cytometry using antibodies against interleukin (IL)-17 and forkhead box P3 (Foxp3), a master regulator of Treg cells.
RESULTS: MSC inhibited Th17 but not Treg differentiation. Under Th17 conditions, MSC did not produce NO, and inhibitors of indoleamine-2,3-dioxygenase (IDO) and prostaglandin E(2) (PGE2) both restored MSC suppression of differentiation, suggesting that MSC suppress Th17 differentiation at least in part through PGE2 and IDO.
CONCLUSIONS: Our results suggest that MSC regulate CD4 differentiation through different mechanisms depending on the culture conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21171824     DOI: 10.3109/14653249.2010.542456

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  34 in total

Review 1.  Multipotent mesenchymal stromal cells and the innate immune system.

Authors:  Katarina Le Blanc; Dimitrios Mougiakakos
Journal:  Nat Rev Immunol       Date:  2012-04-25       Impact factor: 53.106

2.  Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro.

Authors:  H Karlsson; T Erkers; S Nava; S Ruhm; M Westgren; O Ringdén
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 3.  Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells.

Authors:  Antoine Monsel; Ying-Gang Zhu; Stephane Gennai; Qi Hao; Jia Liu; Jae W Lee
Journal:  Anesthesiology       Date:  2014-11       Impact factor: 7.892

Review 4.  Stromal cells-are they really useful for GVHD?

Authors:  H Kaipe; T Erkers; B Sadeghi; O Ringdén
Journal:  Bone Marrow Transplant       Date:  2014-01-27       Impact factor: 5.483

5.  Induction of CD4+CD25+Foxp3+ regulatory T cells by mesenchymal stem cells is associated with RUNX complex factors.

Authors:  Maryam Khosravi; Ali Bidmeshkipour; Ali Moravej; Suzzan Hojjat-Assari; Sina Naserian; Mohammad Hossein Karimi
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

6.  Mesenchymal stromal cells mediate Aspergillus hyphal extract-induced allergic airway inflammation by inhibition of the Th17 signaling pathway.

Authors:  Melissa J Lathrop; Elice M Brooks; Nick R Bonenfant; Dino Sokocevic; Zachary D Borg; Meagan Goodwin; Roberto Loi; Fernanda Cruz; Chad W Dunaway; Chad Steele; Daniel J Weiss
Journal:  Stem Cells Transl Med       Date:  2014-01-16       Impact factor: 6.940

7.  Human adipose-tissue derived mesenchymal stem cells induce functional de-novo regulatory T cells with methylated FOXP3 gene DNA.

Authors:  A U Engela; M J Hoogduijn; K Boer; N H R Litjens; M G H Betjes; W Weimar; C C Baan
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

8.  Impaired immunomodulatory ability of bone marrow mesenchymal stem cells on CD4(+) T cells in aplastic anemia.

Authors:  Jianping Li; Shihong Lu; Shaoguang Yang; Wen Xing; Jianming Feng; Wenqian Li; Qinjun Zhao; Hao Wu; Meili Ge; Fengxia Ma; Hui Zhao; Bin Liu; Lei Zhang; Yizhou Zheng; Zhong Chao Han
Journal:  Results Immunol       Date:  2012-07-28

9.  Prostaglandin E2 affects T cell responses through modulation of CD46 expression.

Authors:  Karoline Kickler; Kathryn Maltby; Siobhán Ni Choileain; Jillian Stephen; Sheila Wright; David A Hafler; Henry N Jabbour; Anne L Astier
Journal:  J Immunol       Date:  2012-04-27       Impact factor: 5.422

Review 10.  Mesenchymal stromal cells in transplantation rejection and tolerance.

Authors:  Karen English; Kathryn J Wood
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.